Pancreatic cancer is a deadly disease that is virtually never cured. Understanding the chemoresistance intrinsic to this cancer will aid in developing new regimens. High expression of APE1/Ref-1, a DNA repair and redox signaling protein, is associated with resistance, poor outcome, and angiogenesis; little is known in pancreatic cancer. Immunostaining of adenocarcinoma shows greater APE1/Ref-1 expression than in normal pancreas tissue. A decrease in APE1/Ref-1 protein levels results in pancreatic cancer cell growth inhibition, increased apoptosis, and altered cell cycle progression. Endogenous cell cycle inhibitors increase when APE1/Ref-1 is reduced, demonstrating its importance to proliferation and growth of pancreatic cancer.
Introduction
Pancreatic cancer is a particularly egregious form of cancer with the worst 5-year survival rate of any cancer: <2% (1) . Pancreatic cancers are hypoxic tumors that respond poorly to existing chemotherapeutic agents and radiation (2) , underscoring the need to understand this type of cancer and develop new strategies to combat it.
Recently, reduction-oxidation (redox) signaling has been identified as an important system to study in pancreatic cancer (2, 3) . We have been studying a DNA repair protein, apurinic/ apyrimidinic endonuclease (APE1/Ref- 1) , that has a second major function in human tumors as a redox signaling protein (and goes by the alternate name of . APE1/Ref-1 interacts with many transcription factors (HIF1-α, p53, AP1, NFκB CREB, and more) to facilitate their DNA binding via reduction of a cysteine residue (reviewed in Refs. 4, 5) . In pancreatic cancer, several of the key transcription factors in controlling angiogenesis and growth such asNFκB, AP1, HIF-1, and STAT3 interact and/or are controlled by APE1/Ref-1's redox activity (5) (6) (7) . The redox function of APE1/Ref-1 is emerging as having an important role in the tumor microenvironment, including pancreatic cancer cell growth, migration, and angiogenesis (3, 8, 9) . In addition to its activity as a redox coactivator of transcription factors, the DNA repair function of APE1/Ref-1 is critical to genomic maintenance. Another well-demonstrated function of APE1/Ref-1 is the transcription cofactor activity, which is separate from its redox activity and has been shown to be essential for cell viability in mouse embryonic fibroblasts (MEFs) (10) .
Many types of tumor cells demonstrate upregulation of APE1/Ref-1 protein levels (4) and then become hypersensitive to chemotherapeutic agents (especially DNA damaging agents) when APE1/Ref-1 protein levels are reduced (11) (12) (13) (14) . Treatment with gemcitabine, the foremost chemotherapeutic agent used in pancreatic cancer, increases protein and activity levels of 
Materials and Methods

Tissue specimens and preparation
Pancreatic tissues were obtained from the Indiana University Simon Cancer Center Tissue Bank. All human tissue samples were collected according to a detailed IRB-approved protocol, informed patient consent, and HIPAA compliance protocol. Tissues were fixed overnight at room temperature in 10% NBF (neutral buffered formalin), then transferred through graded concentrations of alcohol to xylene inside a tissue processor. Tissues were embedded in paraffin before being microtomed into five-micron sections, mounted on positively charged slides and baked at 60°C.
Immunostaining
Paraffin-embedded tissue sections were deparaffinized in running water. The tissues that were fixed in 10% NBF underwent antigen retrieval. Endogenous peroxidase activity was blocked with 3% hydrogen peroxide (Sigma-Aldrich; St. Louis, MO, USA), and antigen retrieval was performed using DAKO Target Retrieval (citrate buffer pH 6.0). Immunostaining was performed using an APE1/Ref-1 antibody with a DAKO LSAB2 kit on a DAKO-automated immunostainer. Visual detection was performed using biotinylated secondary antibody (LSAB2), streptavidin-horseradish peroxidase complex, and DAB chromogen (DAKO). The slides were counterstained with hematoxylin, dehydrated through graded alcohols to xylene, then coverslipped with a permanent mounting medium. Control sections were treated with isotype control at the same concentration as primary antibody to verify the staining specificity. To assess APE1/Ref-1 staining, four independent pathologists evaluated the intensity and localization of the staining. Slides were scored as follows: percentage of cells staining, intensity of IHC stain (referred to as SI) (negative = 0, borderline/minimal = 1, moderate = 2, strong = 3), localization of stain in the cell (none, nuclear, cytoplasm, combination of cytoplasm/ nuclear), and tumor distribution of the stain (homogenous, heterogeneous, focal, multifocal, and/or variable). p Values were calculated using Student's t-test.
Cell lines
Panc-1 and PaCa-2 were purchased from and authenticated by ATCC (Manassas, VA, USA). All cell lines were maintained at 37°C in 5% CO 2 and grown in DMEM media (Invitrogen; Carlsbad, CA, USA) supplemented with 10% Cosmic Calf Serum (Hyclone; Logan, UT, USA) plus an antibiotic/antimycotic (Invitrogen). Sequences of the double-stranded siRNAs are scrambled (5′ CCAUGAGGUCAGCAUGGUCUG 3′, 5′ GACCAUGCUGACCUCAUGGAA 3′) and APE1/Ref-1 (5′ GUCUG-GUACGACUGGAGU ACC 3′, 5′ UACUCCAGUCGUACCAGACCU 3′) as previously described (16) (17) (18) . The 21-base sequence was subjected to a BLAST-search (NCBI) database of EST libraries to ensure that only one gene was targeted. Panc-1 and PaCa-2 cells were plated (1 × 10 4 and 8 × 10 3 cells/ cm 2 , respectively) and allowed to attach overnight. The next day, oligofectamine reagent (Invitrogen) was used to transfect in the siRNA, following the manufacturer's protocol. Opti-MEM, siRNA, and oligofectamine were left on the cells for at least 6 hr; then regular DMEM media was added.
Drugs
Western blot analysis
Cells were harvested, lysed in RIPA buffer (Santa Cruz Biotechnology; Santa Cruz, CA, USA), and protein was quantified and electrophoresed on a 12% SDS-polyacrylamide gel. The following antibodies were used at a dilution of 1:1,000: APE1/Ref-1 (Novus Biologicals; Littleton, CO, USA), Brahma-related gene 1(Brg-1), and mitochondrial cytochrome C oxidase II (mtCOXII) (Santa Cruz Biotechnology), PARP-1 (Cell Signaling Technology Inc.; Danvers, MA, USA), tubulin, and actin (Sigma Aldrich), p21 and p27 (Santa Cruz Biotechnology + 2% BSA), cdc-2 and phospho-cdc-2 (Cell Signaling Technology), and H2AX-γ (Upstate, Waltham, MD). Monoclonal APE/Ref-1 antibodies were produced in the Kelley laboratory and have been extensively used and characterized (19) (20) (21) (22) (23) .
MTS assay for proliferation
Two thousand to 4,000 cells per 96-well plate were allowed to adhere overnight. Following transfection, MTS reagent was added, followed by optical density measurement at 490 nm. The values were standardized to wells containing media alone. To generate the doubling times, the curves in Figure 3 
Colony formation assay
To evaluate cell survival after siRNA transfection, a colony formation assay was used as previously described (24) . Briefly, exponentially growing cells were plated at varying densities 72 hr after transfection. After approximately 12 days, colonies were stained with methylene blue (0.1% w/v) and scored. Percentage survival was calculated based on the plating efficiency of the scrambled control cells.
Apoptosis assays via Alexa Fluor 488-conjugated Annexin-V (Annexin-V)/Propidium Iodide staining
Cells were plated and transfected as described above, and apoptosis was assayed 72 hr after transfection. Cells were trypsinized, pelleted, washed in ice-cold PBS, and resuspended in 1× Binding Buffer (10 mM Hepes/NaOH pH7.4, 140 mM NaCl, 2.5 mM CaCl2). Apoptosis was analyzed using the Alexa Fluor® 488 Annexin-V Vybrant® Apoptosis Assay Kit in combination with propidium iodide (PI) (Molecular Probes; Eugene, OR, USA) as previously described (18) .
Cell cycle staining via BrdU
To stain the cells for DNA content and analyze the movement of cells through G0/G1, S and G2/M, cells were plated, allowed to attach overnight, and transfected as above. On Day 3, cells were processed according to the manufacturer's directions (BD Pharmingen; San Diego, CA, USA) and as previously described (18) . For the BrdU staining with synchronized cells, PaCa-2 cells were synchronized with 100 μM O 6 -benzylguanine (BG) (Sigma Aldrich) for 16 hr prior to adding serum-containing media (24, 25) . Although BG inactivates the DNA repair protein alkylguanine alkyltransferase (AGT or MGMT), treatment with this agent is nontoxic in the absence of DNA-damaging agents in Panc-1 and PaCa-2 cells, as well as mice and humans (26, 27) . Serum-containing media prompted the cells to reenter the cell cycle, allowing us to monitor the cells movement into S phase and G2.
ROS measurement
Oxidant-sensitive probe dihydrorhodamine 123 (DHR) is cell permeable, and oxidized rhodamine123 is preferentially retained by the mitochondria. ROS oxidize the nonfluorescent DHR to the positively charged fluorescent rhodamine 123 and therefore is an effective probe to measure ROS production (3, 13, 28) . The production of ROS was determined by detecting the fluorescent intensity of DHR (Molecular Probes, Invitrogen, Carlsbad, CA, USA). Panc-1 and PaCa-2 cells were transfected with siRNA as described above. As a positive control for ROS production, tert-Butyl hydroperoxide solution (TBHP, 1 mM, 30 min) was utilized. After washing with PBS, the cells were incubated with 1μM DHR in fresh PBS for 30 min. Excessive probe was washed off using PBS. Cells were harvested with trypsin, and ROS fluorescence of labeled cells was measured by using a Coulter EPICS XL flow cytometer (Coulter). An average of 10,000 cells from each sample was counted, and each experiment was done in triplicate. (4, (29) (30) . Therefore, we also isolated mitochondria and found that APE1/Ref-1 protein levels are also reduced by 60% in the mitochondria of Panc-1 and PaCa-2 cells [ Figure 2(B) ]. To confirm this, we purified the mitochondria and probed the blots with mitochondrial-specific protein mtCOXII (mitochondrial cytochrome C oxidase II) (31) . As a nuclear loading control, chromatin-associated protein Brg-1 (Brahma-related gene 1) was utilized. As expected, the mitochondrial preps expressed mtCOXII but not Brg- 
Results
Decreased protein levels of APE1/Ref-1 cause increases in p21 and phosphorylated-cdc-2 levels, confirming G2/M arrest at a molecular level
We quantitated the levels of endogenous cell cycle inhibitors, p21 and p27 as well as monitoring the activity of the kinase responsible for the G2/M transition via phosphorylation of cdc-2 at tyr15 (34) (35) (36) (Figure 4 ). While we observe no change in p27 levels or total cdc-2, the levels 
Discussion
Although alkylating chemotherapeutics are widely used cancer treatments, they have not been clinically effective in treating pancreatic cancer (37) . Gemcitabine, the current standard for pancreatic cancer treatment, primarily demonstrates a palliative effect with isolated cases of long-term tumor regression (38) . Success against this disease is still rare, and different treatment approaches are needed (1, (38) (39) . (41) and yet there is induction of p21, a wellestablished target of p53 transcriptional activity. We speculate that the induction of p21 may be due to p73 activity as p73 has been shown to induce p21 in colorectal cancer cell lines (42) . Furthermore, in the paper by Grau et al., the authors demonstrate induction of p21 in pancreatic cancer cells following treatment with TGFβ indicating that TGFβ signaling may be regulating this response (43) .
At least three possibilities exist to explain the cell cycle arrest: (a) accumulation of DNA damage supported by the H2AX-γ data in Figure 6 (48) or CRT0044876 (7-nitroindole-2-carboxylic acid) (49) . A better understanding of critical pathways and molecular mechanisms involved in pancreatic tumor development, progression, and resistance to traditional therapy is essential to having success against this deadly disease. 
